Lymphatic dissemination in cutaneous leishmaniasis following local treatment

American Journal of Tropical Medicine and Hygiene

Volumn 93, Issue 4, 2015, Pages 770-773

  Thomaidou, Elena ^a   Horev, Liran ^a   Jotkowitz, Deborah ^a   Zamir, Mariana ^a   Ingber, Arieh ^a   Enk, Claes D ^a   Molho Pessach, Vered ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLBENZETHONIUM CHLORIDE; PAROMOMYCIN; PAROMOMYCIN PLUS METHYLBENZETHONIUM CHLORIDE; STIBOGLUCONATE SODIUM; UNCLASSIFIED DRUG; ANTIPROTOZOAL AGENT;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; DRUG WITHDRAWAL; ENDEMIC DISEASE; EROSION; FEMALE; GRANULOMATOSIS; HUMAN; HUMAN TISSUE; INFANT; LEISHMANIA MAJOR; LEISHMANIA TROPICA; LOCAL THERAPY; LYMPH FLOW; LYMPHADENITIS; LYMPHADENOPATHY; LYMPHANGITIS; LYMPHATIC DRAINAGE; MALE; MEDICAL HISTORY; PARASITE VIRULENCE; REGIONAL LYMPHADENOPATHY; REMISSION; SCHOOL CHILD; SINGLE DRUG DOSE; SKIN DEFECT; SKIN LEISHMANIASIS; SKIN ULCER; SPOROTRICHOID SUBCUTANEOUS NODULE; SUBCUTANEOUS NODULE; SYSTEMIC THERAPY; TISSUE INJURY; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME; TREATMENT RESPONSE; COMPLICATION; LEISHMANIASIS, CUTANEOUS; LYMPH NODE; LYMPHATIC DISEASES; PARASITOLOGY; PATHOLOGY;

ADMINISTRATION, TOPICAL; ADOLESCENT; ANTIPROTOZOAL AGENTS; CHILD; FEMALE; HUMANS; INFANT; LEISHMANIASIS, CUTANEOUS; LYMPH NODES; LYMPHATIC DISEASES; MALE;

EID: 84943572431     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.14-0787     Document Type: Article

References (10)

1. Bari AU, 2012. Clinical spectrum of cutaneous leishmaniasis: an overview from Pakistan. Dermatol Online J 18: 4.
2. Burden-Teh E, Wooton CI, Williams HC, 2015. Can a simple outpatient-based treatment be used to treat cutaneous leishmaniasis in young children? A critically appraised topic. Br J Dermatol 172: 861-866.
3. Solomon M, Pavlotsky F, Leshem E, Ephros M, Trau H, Schwartz E, 2011. Liposomal amphotericin B treatment of cutaneous leishmaniasis due to Leishmania tropica. J Eur Acad Dermatol Venereol 25: 973-977.
4. Bailey MS, Caddy AJ, McKinnon KA, Fogg LF, Roscoe M, Bailey JW, O'Dempsey TJ, Beeching NJ, 2012. Outbreak of zoonotic cutaneous leishmaniasis with local dissemination in Balkh, Afghanistan. J R Army Med Corps 158: 225-228.
5. Kibbi AG, Karam PG, Kurban AK, 1987. Sporotrichoid leishmaniasis in patients from Saudi Arabia: clinical and histologic features. J Am Acad Dermatol 17: 759-764.
6. Masmoudi A, Ayadi N, Khabir A, Bouzid L, Bouassida S, Meziou TJ, Akrout F, Zahaf A, Boudawara T, Turki H, 2008. Sporotrichoid cutaneous leishmaniasis in Tunisia: A clinical and histological study. Ann Dermatol Venereol 135: 63-67.
7. Kubba R, El Hassan AM, Al Gindan Y, Omer AHS, Kutty MK, Saeed MBM, 1987. Dissemination in cutaneous leishmaniasis. I. Subcutaneous nodules. Int J Dermatol 26: 300-304.
8. Schonian G, Nasereddin A, Dinse N, Schweynoch C, Schallig HD, Presber W, Jaffe CL, 2003. PCR diagnosis and characterization of Leishmania in local and imported clinical samples. Diagn Microbiol Infect Dis 47: 349-358.
9. Akilov OE, Khachemoune A, Hasan T, 2007. Clinical manifestations and classification of Old World cutaneous leishmaniasis. Int J Dermatol 46: 132-142.
10. Najim RA, Sharquie KE, Al-Zubaidy SA, 2006. Possible mechanisms of action of the compounds injected intralesionally in the treatment of cutaneous leishmaniasis, in addition to their direct effects on the parasites. Ann Trop Med Parasitol 100: 33-38.